{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:53:13Z","timestamp":1776905593023,"version":"3.51.2"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:00:00Z","timestamp":1773619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"fiscal resource modality A of the National Institute of Paediatrics","award":["INP 2018\/017 and INP 2024\/054."],"award-info":[{"award-number":["INP 2018\/017 and INP 2024\/054."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13104-0","type":"journal-article","created":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:47:13Z","timestamp":1773665233000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Landscape of resistance to ceftolozane\/tazobactam and ceftazidime\/avibactam in strains of Pseudomonas aeruginosa: a genomic approach in strains without selection pressure in a tertiary-care paediatric hospital in Mexico"],"prefix":"10.1186","volume":"26","author":[{"given":"H\u00e9ctor E.","family":"A. M\u00e9ndez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jocelin","family":"Merida-Vieyra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"Aparicio-Ozores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Hern\u00e1ndez-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso","family":"M\u00e9ndez-Tenorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Tapia-Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruben","family":"Bautista-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ju\u00e1rez-Hinojos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"Aquino-Andrade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,16]]},"reference":[{"key":"13104_CR1","doi-asserted-by":"publisher","first-page":"dlab117","DOI":"10.1093\/jacamr\/dlab117","volume":"3","author":"HS Sader","year":"2021","unstructured":"Sader HS, Streit JM, Carvalhaes CG, Huband MD, Shortridge D, Mendes RE, et al. Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19). JAC Antimicrob Resist. 2021;3:dlab117. https:\/\/doi.org\/10.1093\/jacamr\/dlab117.","journal-title":"JAC Antimicrob Resist"},{"key":"13104_CR2","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.jiac.2023.04.008","volume":"29","author":"I Tokimatsu","year":"2023","unstructured":"Tokimatsu I, Matsumoto T, Tsukada H, Fujikura Y, Miki M, Morinaga Y, et al. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of the Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2019\u20132020: General view of the pathogens\u2019 antibacterial susceptibility. J Infect Chemother. 2023;29:731\u201343. https:\/\/doi.org\/10.1016\/j.jiac.2023.04.008.","journal-title":"J Infect Chemother"},{"key":"13104_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.jgar.2024.03.020","volume":"37","author":"MG Wise","year":"2024","unstructured":"Wise MG, Karlowsky JA, Mohamed N, Hermsen ED, Kamat S, Townsend A, et al. Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018\u20132022. J Glob Antimicrob Resist. 2024;37:168\u201375. https:\/\/doi.org\/10.1016\/j.jgar.2024.03.020.","journal-title":"J Glob Antimicrob Resist"},{"key":"13104_CR4","doi-asserted-by":"publisher","first-page":"8527","DOI":"10.1038\/s41598-022-12482-0","volume":"12","author":"CM Lee","year":"2022","unstructured":"Lee CM, Kim Y-J, Jung S-I, Kim SE, Park WB, Choe PG, et al. Different clinical characteristics and impact of carbapenem-resistance on outcomes between Acinetobacter baumannii and Pseudomonas aeruginosa bacteraemia: a prospective observational study. Sci Rep. 2022;12:8527. https:\/\/doi.org\/10.1038\/s41598-022-12482-0.","journal-title":"Sci Rep"},{"key":"13104_CR5","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jgar.2024.03.018","volume":"37","author":"F Yuan","year":"2024","unstructured":"Yuan F, Li M, Wang X, Fu Y. Risk factors and mortality of carbapenem-resistant Pseudomonas aeruginosa bloodstream infection in haematology department: A 10-year retrospective study. J Glob Antimicrob Resist. 2024;37:150\u20136. https:\/\/doi.org\/10.1016\/j.jgar.2024.03.018.","journal-title":"J Glob Antimicrob Resist"},{"key":"13104_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/INF.0000000000003832","volume":"42","author":"E Roilides","year":"2023","unstructured":"Roilides E, Ashouri N, Bradley JS, Johnson MG, Lonchar J, Su F-H, et al. Safety and Efficacy of Ceftolozane\/Tazobactam Versus Meropenem in Neonates and Children With Complicated Urinary Tract Infection, Including Pyelonephritis: A Phase 2, Randomized Clinical Trial. Pediatr Infect Dis J. 2023;42:292\u20138. https:\/\/doi.org\/10.1097\/INF.0000000000003832.","journal-title":"Pediatr Infect Dis J"},{"key":"13104_CR7","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1097\/INF.0000000000002170","volume":"37","author":"JS Bradley","year":"2018","unstructured":"Bradley JS, Ang JY, Arrieta AC, Larson KB, Rizk ML, Caro L, et al. Pharmacokinetics and Safety of Single Intravenous Doses of Ceftolozane\/Tazobactam in Children With Proven or Suspected Gram-Negative Infection. Pediatr Infect Dis J. 2018;37:1130\u20136. https:\/\/doi.org\/10.1097\/INF.0000000000002170.","journal-title":"Pediatr Infect Dis J"},{"key":"13104_CR8","doi-asserted-by":"publisher","first-page":"e01960","DOI":"10.1128\/JCM.01960-17","volume":"56","author":"HS Sader","year":"2018","unstructured":"Sader HS, Rhomberg PR, Huband MD, Critchley IA, Stone GG, Flamm RK, et al. Assessment of 30\/20-Microgram Disk Content versus MIC Results for Ceftazidime-Avibactam Tested against Enterobacteriaceae and Pseudomonas aeruginosa. J Clin Microbiol. 2018;56:e01960\u201317. https:\/\/doi.org\/10.1128\/JCM.01960-17.","journal-title":"J Clin Microbiol"},{"key":"13104_CR9","doi-asserted-by":"publisher","first-page":"e0206721","DOI":"10.1128\/AAC.02067-21","volume":"66","author":"A Ruedas-L\u00f3pez","year":"2022","unstructured":"Ruedas-L\u00f3pez A, Alonso-Garc\u00eda I, Lasarte-Monterrubio C, Guijarro-S\u00e1nchez P, Gato E, V\u00e1zquez-Ucha JC, et al. Selection of AmpC \u03b2-Lactamase Variants and Metallo-\u03b2-Lactamases Leading to Ceftolozane\/Tazobactam and Ceftazidime\/Avibactam Resistance during Treatment of MDR\/XDR Pseudomonas aeruginosa Infections. Antimicrob Agents Chemother. 2022;66:e0206721. https:\/\/doi.org\/10.1128\/AAC.02067-21.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR10","doi-asserted-by":"publisher","first-page":"5815","DOI":"10.2147\/IDR.S426326","volume":"16","author":"H Meng","year":"2023","unstructured":"Meng H, Zhao Y, An Q, Zhu B, Cao Z, Lu J. Use of Ceftazidime-Avibactam for Suspected or Confirmed Carbapenem-Resistant Organisms in Children: A Retrospective Study. Infect Drug Resist. 2023;16:5815\u201324. https:\/\/doi.org\/10.2147\/IDR.S426326.","journal-title":"Infect Drug Resist"},{"key":"13104_CR11","unstructured":"Consulta de Registros Sanitarios. https:\/\/tramiteselectronicos02.cofepris.gob.mx\/BuscadorPublicoRegistrosSanitarios\/BusquedaRegistroSanitario.aspx. Accessed 21 July 2025."},{"key":"13104_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1093\/jpids\/piad055","volume":"12","author":"Q Yang","year":"2023","unstructured":"Yang Q, Kamat S, Mohamed N, Valdez RR, Lin S, Su M, et al. Antimicrobial Susceptibility Among Gram-Negative Isolates in Pediatric Patients in Latin America, Africa-Middle East, and Asia From 2016\u20132020 Compared to 2011\u20132015: Results From the ATLAS Surveillance Study. J Pediatr Infect Dis Soc. 2023;12:459\u201370. https:\/\/doi.org\/10.1093\/jpids\/piad055.","journal-title":"J Pediatr Infect Dis Soc"},{"key":"13104_CR13","doi-asserted-by":"publisher","first-page":"e00084","DOI":"10.1128\/AAC.00084-21","volume":"65","author":"AM Rubio","year":"2021","unstructured":"Rubio AM, Kline EG, Jones CE, Chen L, Kreiswirth BN, Nguyen MH, et al. In Vitro Susceptibility of Multidrug-Resistant Pseudomonas aeruginosa following Treatment-Emergent Resistance to Ceftolozane-Tazobactam. Antimicrob Agents Chemother. 2021;65:e00084\u201321. https:\/\/doi.org\/10.1128\/AAC.00084-21.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR14","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/antibiotics11070871","volume":"11","author":"R Recio","year":"2022","unstructured":"Recio R, Villa J, Gonz\u00e1lez-Bod\u00ed S, Bra\u00f1as P, Orellana M\u00c1, Manche\u00f1o-Losa M, et al. Genomic Analysis of Ceftazidime\/Avibactam-Resistant GES-Producing Sequence Type 235 Pseudomonas aeruginosa Isolates. Antibiot (Basel). 2022;11:871. https:\/\/doi.org\/10.3390\/antibiotics11070871.","journal-title":"Antibiot (Basel)"},{"key":"13104_CR15","doi-asserted-by":"publisher","first-page":"1098944","DOI":"10.3389\/fcimb.2023.1098944","volume":"13","author":"B Babouee Flury","year":"2023","unstructured":"Babouee Flury B, B\u00f6sch A, Gisler V, Egli A, Seiffert SN, Nolte O, et al. Multifactorial resistance mechanisms associated with resistance to ceftazidime-avibactam in clinical Pseudomonas aeruginosa isolates from Switzerland. Front Cell Infect Microbiol. 2023;13:1098944. https:\/\/doi.org\/10.3389\/fcimb.2023.1098944.","journal-title":"Front Cell Infect Microbiol"},{"key":"13104_CR16","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.idc.2020.05.001","volume":"34","author":"KM Papp-Wallace","year":"2020","unstructured":"Papp-Wallace KM, Mack AR, Taracila MA, Bonomo RA. Resistance to Novel \u03b2-Lactam-\u03b2-Lactamase Inhibitor Combinations: The Price of Progress. Infect Dis Clin North Am. 2020;34:773\u2013819. https:\/\/doi.org\/10.1016\/j.idc.2020.05.001.","journal-title":"Infect Dis Clin North Am"},{"key":"13104_CR17","doi-asserted-by":"publisher","first-page":"e01379","DOI":"10.1128\/AAC.01379-18","volume":"62","author":"F Sanz-Garc\u00eda","year":"2018","unstructured":"Sanz-Garc\u00eda F, Hernando-Amado S, Mart\u00ednez JL. Mutation-Driven Evolution of Pseudomonas aeruginosa in the Presence of either Ceftazidime or Ceftazidime-Avibactam. Antimicrob Agents Chemother. 2018;62:e01379\u201318. https:\/\/doi.org\/10.1128\/AAC.01379-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR18","doi-asserted-by":"publisher","first-page":"106877","DOI":"10.1016\/j.ijantimicag.2023.106877","volume":"62","author":"L Xiong","year":"2023","unstructured":"Xiong L, Wang Y, Wang X, Zhou Y, Chi X, Chen T, et al. Mechanisms of ceftazidime\/avibactam resistance in drug-na\u00efve bacteraemic Enterobacterales strains without metallo-beta-lactamase production: Associated with ceftazidime impedance. Int J Antimicrob Agents. 2023;62:106877. https:\/\/doi.org\/10.1016\/j.ijantimicag.2023.106877.","journal-title":"Int J Antimicrob Agents"},{"key":"13104_CR19","doi-asserted-by":"publisher","first-page":"592","DOI":"10.24875\/GMM.M21000491","volume":"156","author":"R Mart\u00ednez-Miranda","year":"2020","unstructured":"Mart\u00ednez-Miranda R, Gast\u00e9lum-Acosta M, Guerrero-Estrada P, Ayala-Figueroa RI, Osuna-\u00c1lvarez LE. Ceftolozane\/tazobactam and ceftazidime\/avibactam antimicrobial activity against clinically relevant gram-negative bacilli isolated in Mexico. Gac Med Mex. 2020;156:592\u20137. https:\/\/doi.org\/10.24875\/GMM.M21000491.","journal-title":"Gac Med Mex"},{"key":"13104_CR20","doi-asserted-by":"publisher","first-page":"e0065122","DOI":"10.1128\/msphere.00651-22","volume":"8","author":"MF Mojica","year":"2023","unstructured":"Mojica MF, De La Cadena E, Garc\u00eda-Betancur JC, Porras J, Novoa-Caicedo I, P\u00e1ez-Zamora L, et al. Molecular Mechanisms of Resistance to Ceftazidime\/Avibactam in Clinical Isolates of Enterobacterales and Pseudomonas aeruginosa in Latin American Hospitals. mSphere. 2023;8:e0065122. https:\/\/doi.org\/10.1128\/msphere.00651-22.","journal-title":"mSphere"},{"key":"13104_CR21","doi-asserted-by":"publisher","first-page":"dlad152","DOI":"10.1093\/jacamr\/dlad152","volume":"6","author":"JA Karlowsky","year":"2024","unstructured":"Karlowsky JA, Lob SH, Bauer KA, Esterly J, Siddiqui F, Young K, et al. Activity of ceftolozane\/tazobactam, imipenem\/relebactam and ceftazidime\/avibactam against clinical Gram-negative isolates-SMART United States 2019-21. JAC Antimicrob Resist. 2024;6:dlad152. https:\/\/doi.org\/10.1093\/jacamr\/dlad152.","journal-title":"JAC Antimicrob Resist"},{"key":"13104_CR22","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. CLSI supplement M100. 2024."},{"key":"13104_CR23","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1093\/jac\/dkp498","volume":"65","author":"C Dallenne","year":"2010","unstructured":"Dallenne C, Da Costa A, Decr\u00e9 D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother. 2010;65:490\u20135. https:\/\/doi.org\/10.1093\/jac\/dkp498.","journal-title":"J Antimicrob Chemother"},{"key":"13104_CR24","doi-asserted-by":"publisher","first-page":"e0163962","DOI":"10.1371\/journal.pone.0163962","volume":"11","author":"W Shen","year":"2016","unstructured":"Shen W, Le S, Li Y, Hu F, SeqKit:. A Cross-Platform and Ultrafast Toolkit for FASTA\/Q File Manipulation. PLoS ONE. 2016;11:e0163962. https:\/\/doi.org\/10.1371\/journal.pone.0163962.","journal-title":"PLoS ONE"},{"key":"13104_CR25","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170.","journal-title":"Bioinformatics"},{"key":"13104_CR26","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1089\/cmb.2012.0021","volume":"19","author":"A Bankevich","year":"2012","unstructured":"Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, et al. SPAdes: A New Genome Assembly Algorithm and Its Applications to Single-Cell Sequencing. J Comput Biol. 2012;19:455\u201377. https:\/\/doi.org\/10.1089\/cmb.2012.0021.","journal-title":"J Comput Biol"},{"key":"13104_CR27","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1002\/cpbi.102","volume":"70","author":"A Prjibelski","year":"2020","unstructured":"Prjibelski A, Antipov D, Meleshko D, Lapidus A, Korobeynikov A. Using SPAdes De Novo Assembler. Curr Protoc Bioinf. 2020;70:e102. https:\/\/doi.org\/10.1002\/cpbi.102.","journal-title":"Curr Protoc Bioinf"},{"key":"13104_CR28","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1101\/gr.2289704","volume":"14","author":"ACE Darling","year":"2004","unstructured":"Darling ACE, Mau B, Blattner FR, Perna NT. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 2004;14:1394\u2013403. https:\/\/doi.org\/10.1101\/gr.2289704.","journal-title":"Genome Res"},{"key":"13104_CR29","doi-asserted-by":"publisher","first-page":"i142","DOI":"10.1093\/bioinformatics\/bty266","volume":"34","author":"A Mikheenko","year":"2018","unstructured":"Mikheenko A, Prjibelski A, Saveliev V, Antipov D, Gurevich A. Versatile genome assembly evaluation with QUAST-LG. Bioinformatics. 2018;34:i142\u201350. https:\/\/doi.org\/10.1093\/bioinformatics\/bty266.","journal-title":"Bioinformatics"},{"key":"13104_CR30","doi-asserted-by":"publisher","unstructured":"Minot SS, Krumm N, Greenfield NB, One Codex. A Sensitive and Accurate Data Platform for Genomic Microbial Identification. 2015;:027607. https:\/\/doi.org\/10.1101\/027607","DOI":"10.1101\/027607"},{"key":"13104_CR31","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","volume":"3","author":"KA Jolley","year":"2018","unstructured":"Jolley KA, Bray JE, Maiden MCJ. Open-access bacterial population genomics: BIGSdb software, the PubMLST.org website and their applications. Wellcome Open Res. 2018;3:124. https:\/\/doi.org\/10.12688\/wellcomeopenres.14826.1.","journal-title":"Wellcome Open Res"},{"key":"13104_CR32","doi-asserted-by":"publisher","first-page":"e000166","DOI":"10.1099\/mgen.0.000166","volume":"4","author":"M Silva","year":"2018","unstructured":"Silva M, Machado MP, Silva DN, Rossi M, Moran-Gilad J, Santos S, et al. chewBBACA: A complete suite for gene-by-gene schema creation and strain identification. Microb Genom. 2018;4:e000166. https:\/\/doi.org\/10.1099\/mgen.0.000166.","journal-title":"Microb Genom"},{"key":"13104_CR33","doi-asserted-by":"publisher","first-page":"W246","DOI":"10.1093\/nar\/gkw359","volume":"44","author":"B Ribeiro-Gon\u00e7alves","year":"2016","unstructured":"Ribeiro-Gon\u00e7alves B, Francisco AP, Vaz C, Ramirez M, Carri\u00e7o JA. PHYLOViZ Online: web-based tool for visualization, phylogenetic inference, analysis and sharing of minimum spanning trees. Nucleic Acids Res. 2016;44:W246\u2013251. https:\/\/doi.org\/10.1093\/nar\/gkw359.","journal-title":"Nucleic Acids Res"},{"key":"13104_CR34","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/jac\/dkaa390","volume":"76","author":"MHK Johansson","year":"2021","unstructured":"Johansson MHK, Bortolaia V, Tansirichaiya S, Aarestrup FM, Roberts AP, Petersen TN. Detection of mobile genetic elements associated with antibiotic resistance in Salmonella enterica using a newly developed web tool: MobileElementFinder. J Antimicrob Chemother. 2021;76:101\u20139. https:\/\/doi.org\/10.1093\/jac\/dkaa390.","journal-title":"J Antimicrob Chemother"},{"key":"13104_CR35","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1093\/jac\/dkaa345","volume":"75","author":"V Bortolaia","year":"2020","unstructured":"Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, et al. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother. 2020;75:3491\u2013500. https:\/\/doi.org\/10.1093\/jac\/dkaa345.","journal-title":"J Antimicrob Chemother"},{"key":"13104_CR36","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1093\/jac\/dkx217","volume":"72","author":"E Zankari","year":"2017","unstructured":"Zankari E, Alles\u00f8e R, Joensen KG, Cavaco LM, Lund O, Aarestrup FM. PointFinder: a novel web tool for WGS-based detection of antimicrobial resistance associated with chromosomal point mutations in bacterial pathogens. J Antimicrob Chemother. 2017;72:2764\u20138. https:\/\/doi.org\/10.1093\/jac\/dkx217.","journal-title":"J Antimicrob Chemother"},{"key":"13104_CR37","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12859-018-2336-6","volume":"19","author":"PTLC Clausen","year":"2018","unstructured":"Clausen PTLC, Aarestrup FM, Lund O. Rapid and precise alignment of raw reads against redundant databases with KMA. BMC Bioinformatics. 2018;19:307. https:\/\/doi.org\/10.1186\/s12859-018-2336-6.","journal-title":"BMC Bioinformatics"},{"key":"13104_CR38","unstructured":"snippy. rapid haploid variant calling and core genome alignment. https:\/\/hpc.nih.gov\/apps\/snippy.html. Accessed 21 July 2025."},{"key":"13104_CR39","doi-asserted-by":"publisher","first-page":"D912","DOI":"10.1093\/nar\/gkab1107","volume":"50","author":"B Liu","year":"2022","unstructured":"Liu B, Zheng D, Zhou S, Chen L, Yang J. VFDB 2022: a general classification scheme for bacterial virulence factors. Nucleic Acids Res. 2022;50:D912\u20137. https:\/\/doi.org\/10.1093\/nar\/gkab1107.","journal-title":"Nucleic Acids Res"},{"key":"13104_CR40","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s13059-020-02090-4","volume":"21","author":"G Tonkin-Hill","year":"2020","unstructured":"Tonkin-Hill G, MacAlasdair N, Ruis C, Weimann A, Horesh G, Lees JA, et al. Producing polished prokaryotic pangenomes with the Panaroo pipeline. Genome Biol. 2020;21:180. https:\/\/doi.org\/10.1186\/s13059-020-02090-4.","journal-title":"Genome Biol"},{"key":"13104_CR41","unstructured":"R Core Team. R: A language and environment for statistical computing [Internet]. Viena, Austria: R Foundation for Statistical Computing. 2025. Disponible en: https:\/\/www.R-project.org\/"},{"key":"13104_CR42","unstructured":"ggplot2. Elegant Graphics for Data Analysis (3e). https:\/\/ggplot2-book.org\/. Accessed 11 Aug 2025."},{"key":"13104_CR43","doi-asserted-by":"publisher","first-page":"e104984","DOI":"10.1371\/journal.pone.0104984","volume":"9","author":"RS Kaas","year":"2014","unstructured":"Kaas RS, Leekitcharoenphon P, Aarestrup FM, Lund O. Solving the problem of comparing whole bacterial genomes across different sequencing platforms. PLoS ONE. 2014;9:e104984. https:\/\/doi.org\/10.1371\/journal.pone.0104984.","journal-title":"PLoS ONE"},{"key":"13104_CR44","doi-asserted-by":"publisher","first-page":"e01117","DOI":"10.1128\/AAC.01117-20","volume":"65","author":"D Fournier","year":"2021","unstructured":"Fournier D, Carri\u00e8re R, Bour M, Grisot E, Triponney P, Muller C, et al. Mechanisms of Resistance to Ceftolozane\/Tazobactam in Pseudomonas aeruginosa: Results of the GERPA Multicenter Study. Antimicrob Agents Chemother. 2021;65:e01117\u201320. https:\/\/doi.org\/10.1128\/AAC.01117-20.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR45","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1080\/22221751.2021.1968318","volume":"10","author":"JQ-M Teo","year":"2021","unstructured":"Teo JQ-M, Tang CY, Lim JC, Lee SJ-Y, Tan SH, Koh T-H, et al. Genomic characterization of carbapenem-non-susceptible Pseudomonas aeruginosa in Singapore. Emerg Microbes Infect. 2021;10:1706\u201316. https:\/\/doi.org\/10.1080\/22221751.2021.1968318.","journal-title":"Emerg Microbes Infect"},{"key":"13104_CR46","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3390\/antibiotics13020159","volume":"13","author":"R Papa-Ezdra","year":"2024","unstructured":"Papa-Ezdra R, Outeda M, Cordeiro NF, Ara\u00fajo L, Gadea P, Garcia-Fulgueiras V, et al. Outbreak of Pseudomonas aeruginosa High-Risk Clone ST309 Serotype O11 Featuring blaPER-1 and qnrVC6. Antibiot (Basel). 2024;13:159. https:\/\/doi.org\/10.3390\/antibiotics13020159.","journal-title":"Antibiot (Basel)"},{"key":"13104_CR47","doi-asserted-by":"publisher","unstructured":"Alvarado-Orosco N, Gomis-Font MA, Sastre-Femenia MA, Ribera Ortiz S, Miranda Arce M, Ara\u00faz Barba ME, et al. First nationwide survey on Pseudomonas aeruginosa in Bolivia: susceptibility profiles, resistome, and genomic epidemiology. Antimicrob Agents Chemother. 2025;e0116325. https:\/\/doi.org\/10.1128\/aac.01163-25.","DOI":"10.1128\/aac.01163-25"},{"key":"13104_CR48","doi-asserted-by":"publisher","first-page":"W587","DOI":"10.1093\/nar\/gkad359","volume":"51","author":"J Xie","year":"2023","unstructured":"Xie J, Chen Y, Cai G, Cai R, Hu Z, Wang H. Tree Visualization By One Table (tvBOT): a web application for visualizing, modifying and annotating phylogenetic trees. Nucleic Acids Res. 2023;51:W587\u201392. https:\/\/doi.org\/10.1093\/nar\/gkad359.","journal-title":"Nucleic Acids Res"},{"key":"13104_CR49","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.jgar.2024.05.017","volume":"38","author":"X Mu","year":"2024","unstructured":"Mu X, Fu Y, Li P, Yu Y. In vitro activity of ceftolozane\/tazobactam against Gram-negative bacilli isolated from pediatric patients: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017\u20132021, China. J Glob Antimicrob Resist. 2024;38:216\u201322. https:\/\/doi.org\/10.1016\/j.jgar.2024.05.017.","journal-title":"J Glob Antimicrob Resist"},{"key":"13104_CR50","doi-asserted-by":"publisher","first-page":"e0277","DOI":"10.1590\/0037-8682-0277-2022","volume":"56","author":"TN Carvalho","year":"2023","unstructured":"Carvalho TN, Kobs VC, Hille D, Deglmann RC, Melo LH, de Fran\u00e7a PHC. Evaluation of in-vitro susceptibility of \u00df-lactam-resistant Gram-negative bacilli to ceftazidime-avibactam and ceftolozane-tazobactam from clinical samples of a general hospital in southern Brazil. Rev Soc Bras Med Trop. 2023;56:e0277\u20132022. https:\/\/doi.org\/10.1590\/0037-8682-0277-2022.","journal-title":"Rev Soc Bras Med Trop"},{"key":"13104_CR51","doi-asserted-by":"publisher","first-page":"e0169722","DOI":"10.1128\/spectrum.01697-22","volume":"10","author":"C Weber","year":"2022","unstructured":"Weber C, Schultze T, G\u00f6ttig S, Kessel J, Schr\u00f6der A, Tietgen M, et al. Antimicrobial Activity of Ceftolozane-Tazobactam, Ceftazidime-Avibactam, and Cefiderocol against Multidrug-Resistant Pseudomonas aeruginosa Recovered at a German University Hospital. Microbiol Spectr. 2022;10:e0169722. https:\/\/doi.org\/10.1128\/spectrum.01697-22.","journal-title":"Microbiol Spectr"},{"key":"13104_CR52","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1093\/jac\/dky425","volume":"74","author":"S-C Hsueh","year":"2019","unstructured":"Hsueh S-C, Lee Y-J, Huang Y-T, Liao C-H, Tsuji M, Hsueh P-R. In vitro activities of cefiderocol, ceftolozane\/tazobactam, ceftazidime\/avibactam and other comparative drugs against imipenem-resistant Pseudomonas aeruginosa and Acinetobacter baumannii, and Stenotrophomonas maltophilia, all associated with bloodstream infections in Taiwan. J Antimicrob Chemother. 2019;74:380\u20136. https:\/\/doi.org\/10.1093\/jac\/dky425.","journal-title":"J Antimicrob Chemother"},{"key":"13104_CR53","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1093\/cid\/ciae332","volume":"80","author":"S Shah","year":"2025","unstructured":"Shah S, Kline EG, Haidar G, Squires KM, Pogue JM, McCreary EK, et al. Rates of Resistance to Ceftazidime-Avibactam and Ceftolozane-Tazobactam Among Patients Treated for Multidrug-Resistant Pseudomonas aeruginosa Bacteremia or Pneumonia. Clin Infect Dis. 2025;80:24\u20138. https:\/\/doi.org\/10.1093\/cid\/ciae332.","journal-title":"Clin Infect Dis"},{"key":"13104_CR54","doi-asserted-by":"publisher","first-page":"e0040523","DOI":"10.1128\/aac.00405-23","volume":"67","author":"TA Almangour","year":"2023","unstructured":"Almangour TA, Ghonem L, Alassiri D, Aljurbua A, Al Musawa M, Alharbi A, et al. Ceftolozane-Tazobactam Versus Ceftazidime-Avibactam for the Treatment of Infections Caused by Multidrug-Resistant Pseudomonas aeruginosa: a Multicenter Cohort Study. Antimicrob Agents Chemother. 2023;67:e0040523. https:\/\/doi.org\/10.1128\/aac.00405-23.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR55","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"PD Tamma","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum \u03b2-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022;75:187\u2013212. https:\/\/doi.org\/10.1093\/cid\/ciac268.","journal-title":"Clin Infect Dis"},{"key":"13104_CR56","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3390\/antibiotics13020191","volume":"13","author":"AJ Gondal","year":"2024","unstructured":"Gondal AJ, Choudhry N, Niaz A, Yasmin N. Molecular Analysis of Carbapenem and Aminoglycoside Resistance Genes in Carbapenem-Resistant Pseudomonas aeruginosa Clinical Strains: A Challenge for Tertiary Care Hospitals. Antibiot (Basel). 2024;13:191. https:\/\/doi.org\/10.3390\/antibiotics13020191.","journal-title":"Antibiot (Basel)"},{"key":"13104_CR57","doi-asserted-by":"publisher","first-page":"106507","DOI":"10.1016\/j.ijantimicag.2021.106507","volume":"59","author":"\u00c9L Fonseca","year":"2022","unstructured":"Fonseca \u00c9L, Morgado SM, Caldart RV, Freitas F, Vicente ACP. Emergence of a VIM-2-producing extensively drug-resistant (XDR) Pseudomonas aeruginosa ST309 in South America: a comparative genomic analysis. Int J Antimicrob Agents. 2022;59:106507. https:\/\/doi.org\/10.1016\/j.ijantimicag.2021.106507.","journal-title":"Int J Antimicrob Agents"},{"key":"13104_CR58","doi-asserted-by":"publisher","first-page":"ofz273","DOI":"10.1093\/ofid\/ofz273","volume":"6","author":"A Khan","year":"2019","unstructured":"Khan A, Tran TT, Rios R, Hanson B, Shropshire WC, Sun Z, et al. Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum \u03b2-Lactamase Enzymes: A Newly Emerging Threat in the United States. Open Forum Infect Dis. 2019;6:ofz273. https:\/\/doi.org\/10.1093\/ofid\/ofz273.","journal-title":"Open Forum Infect Dis"},{"key":"13104_CR59","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3389\/fmicb.2017.00313","volume":"8","author":"R Morales-Espinosa","year":"2017","unstructured":"Morales-Espinosa R, Delgado G, Espinosa LF, Isselo D, M\u00e9ndez JL, Rodriguez C, et al. Fingerprint Analysis and Identification of Strains ST309 as a Potential High Risk Clone in a Pseudomonas aeruginosa Population Isolated from Children with Bacteremia in Mexico City. Front Microbiol. 2017;8:313. https:\/\/doi.org\/10.3389\/fmicb.2017.00313.","journal-title":"Front Microbiol"},{"key":"13104_CR60","doi-asserted-by":"publisher","first-page":"7509","DOI":"10.1128\/AEM.01279-15","volume":"81","author":"F Abdouchakour","year":"2015","unstructured":"Abdouchakour F, Dupont C, Grau D, Aujoulat F, Mournetas P, Marchandin H, et al. Pseudomonas aeruginosa and Achromobacter sp. clonal selection leads to successive waves of contamination of water in dental care units. Appl Environ Microbiol. 2015;81:7509\u201324. https:\/\/doi.org\/10.1128\/AEM.01279-15.","journal-title":"Appl Environ Microbiol"},{"key":"13104_CR61","doi-asserted-by":"publisher","first-page":"e14487","DOI":"10.1111\/1751-7915.14487","volume":"17","author":"W Wu","year":"2024","unstructured":"Wu W, Huang J, Xu Z. Antibiotic influx and efflux in Pseudomonas aeruginosa: Regulation and therapeutic implications. Microb Biotechnol. 2024;17:e14487. https:\/\/doi.org\/10.1111\/1751-7915.14487.","journal-title":"Microb Biotechnol"},{"key":"13104_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.diagmicrobio.2017.06.008","volume":"89","author":"S Balero de Paula","year":"2017","unstructured":"Balero de Paula S, Cay\u00f4 R, Streling AP, Silva Nodari C, Pereira Matos A, Eches Perugini MR, et al. Detection of blaVIM-7 in an extensively drug-resistant Pseudomonas aeruginosa isolate belonging to ST1284 in Brazil. Diagn Microbiol Infect Dis. 2017;89:80\u20132. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2017.06.008.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"13104_CR63","doi-asserted-by":"publisher","first-page":"e96","DOI":"10.1017\/ash.2022.226","volume":"2","author":"MA Sid Ahmed","year":"2022","unstructured":"Sid Ahmed MA, Abdel Hadi H, Abu Jarir S, Ahmad Khan F, Arbab MA, Hamid JM, et al. Prevalence and microbiological and genetic characteristics of multidrug-resistant Pseudomonas aeruginosa over three years in Qatar. Antimicrob Steward Healthc Epidemiol. 2022;2:e96. https:\/\/doi.org\/10.1017\/ash.2022.226.","journal-title":"Antimicrob Steward Healthc Epidemiol"},{"key":"13104_CR64","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1111\/j.1469-0691.2011.03466.x","volume":"17","author":"S Pollini","year":"2011","unstructured":"Pollini S, Fiscarelli E, Mugnaioli C, Di Pilato V, Ricciotti G, Neri AS, et al. Pseudomonas aeruginosa infection in cystic fibrosis caused by an epidemic metallo-\u03b2-lactamase-producing clone with a heterogeneous carbapenem resistance phenotype. Clin Microbiol Infect. 2011;17:1272\u20135. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03466.x.","journal-title":"Clin Microbiol Infect"},{"key":"13104_CR65","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jgar.2024.07.003","volume":"38","author":"J Zurita","year":"2024","unstructured":"Zurita J, Sevillano G, Sol\u00eds MB, Paz Y, Mi\u00f1o A, Alves BR, Changuan J, et al. Pseudomonas aeruginosa epidemic high-risk clones and their association with multidrug-resistant. J Glob Antimicrob Resist. 2024;38:332\u20138. https:\/\/doi.org\/10.1016\/j.jgar.2024.07.003.","journal-title":"J Glob Antimicrob Resist"},{"key":"13104_CR66","doi-asserted-by":"publisher","unstructured":"Boralli CMDS, Paganini JA, Meneses RS, Mata CPSM da, Leite EMM, Sch\u00fcrch AC, et al., et al. Characterization of blaKPC-2 and blaNDM-1 Plasmids of a K. pneumoniae ST11 Outbreak Clone. Antibiot (Basel). 2023;12:926. https:\/\/doi.org\/10.3390\/antibiotics12050926.","DOI":"10.3390\/antibiotics12050926"},{"key":"13104_CR67","doi-asserted-by":"publisher","first-page":"dlab015","DOI":"10.1093\/jacamr\/dlab015","volume":"3","author":"P Manohar","year":"2021","unstructured":"Manohar P, Leptihn S, Lopes BS, Nachimuthu R. Dissemination of carbapenem resistance and plasmids encoding carbapenemases in Gram-negative bacteria isolated in India. JAC Antimicrob Resist. 2021;3:dlab015. https:\/\/doi.org\/10.1093\/jacamr\/dlab015.","journal-title":"JAC Antimicrob Resist"},{"key":"13104_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3390\/cells12010199","volume":"12","author":"SJ Wood","year":"2023","unstructured":"Wood SJ, Kuzel TM, Shafikhani SH. Pseudomonas aeruginosa: Infections, Animal Modeling, and Therapeutics. Cells. 2023;12:199. https:\/\/doi.org\/10.3390\/cells12010199.","journal-title":"Cells"},{"key":"13104_CR69","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/978-3-031-08491-1_12","volume":"1386","author":"S Pont","year":"2022","unstructured":"Pont S, Janet-Maitre M, Faudry E, Cretin F, Attr\u00e9e I. Molecular Mechanisms Involved in Pseudomonas aeruginosa Bacteremia. Adv Exp Med Biol. 2022;1386:325\u201345. https:\/\/doi.org\/10.1007\/978-3-031-08491-1_12.","journal-title":"Adv Exp Med Biol"},{"key":"13104_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/2049-632X.12208","volume":"73","author":"D Balasubramanian","year":"2015","unstructured":"Balasubramanian D, Kumari H, Mathee K. Pseudomonas aeruginosa AmpR: an acute-chronic switch regulator. Pathog Dis. 2015;73:1\u201314. https:\/\/doi.org\/10.1111\/2049-632X.12208.","journal-title":"Pathog Dis"},{"key":"13104_CR71","doi-asserted-by":"publisher","first-page":"6349","DOI":"10.1128\/AAC.01388-12","volume":"56","author":"G Cabot","year":"2012","unstructured":"Cabot G, Ocampo-Sosa AA, Dom\u00ednguez MA, Gago JF, Juan C, Tubau F, et al. Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones. Antimicrob Agents Chemother. 2012;56:6349\u201357. https:\/\/doi.org\/10.1128\/AAC.01388-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR72","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1128\/AAC.00574-09","volume":"53","author":"J-M Rodr\u00edguez-Mart\u00ednez","year":"2009","unstructured":"Rodr\u00edguez-Mart\u00ednez J-M, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2009;53:4783\u20138. https:\/\/doi.org\/10.1128\/AAC.00574-09.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR73","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1093\/jac\/dky393","volume":"74","author":"W So","year":"2019","unstructured":"So W, Shurko J, Galega R, Quilitz R, Greene JN, Lee GC. Mechanisms of high-level ceftolozane\/tazobactam resistance in Pseudomonas aeruginosa from a severely neutropenic patient and treatment success from synergy with tobramycin. J Antimicrob Chemother. 2019;74:269\u201371. https:\/\/doi.org\/10.1093\/jac\/dky393.","journal-title":"J Antimicrob Chemother"},{"key":"13104_CR74","doi-asserted-by":"publisher","first-page":"15779","DOI":"10.3390\/ijms232415779","volume":"23","author":"AB Lorusso","year":"2022","unstructured":"Lorusso AB, Carrara JA, Barroso CDN, Tuon FF, Faoro H. Role of Efflux Pumps on Antimicrobial Resistance in Pseudomonas aeruginosa. Int J Mol Sci. 2022;23:15779. https:\/\/doi.org\/10.3390\/ijms232415779.","journal-title":"Int J Mol Sci"},{"key":"13104_CR75","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3390\/antibiotics11010030","volume":"11","author":"Y Yuan","year":"2021","unstructured":"Yuan Y, Rosado-Lugo JD, Zhang Y, Datta P, Sun Y, Cao Y, et al. Evaluation of Heterocyclic Carboxamides as Potential Efflux Pump Inhibitors in Pseudomonas aeruginosa. Antibiot (Basel). 2021;11:30. https:\/\/doi.org\/10.3390\/antibiotics11010030.","journal-title":"Antibiot (Basel)"},{"key":"13104_CR76","doi-asserted-by":"publisher","first-page":"1007162","DOI":"10.3389\/fphar.2022.1007162","volume":"13","author":"MJ Contreras-G\u00f3mez","year":"2022","unstructured":"Contreras-G\u00f3mez MJ, Martinez JRW, Rivas L, Riquelme-Neira R, Ugalde JA, Wozniak A, et al. Role of the multi-drug efflux systems on the baseline susceptibility to ceftazidime\/avibactam and ceftolozane\/tazobactam in clinical isolates of non-carbapenemase-producing carbapenem-resistant Pseudomonas aeruginosa. Front Pharmacol. 2022;13:1007162. https:\/\/doi.org\/10.3389\/fphar.2022.1007162.","journal-title":"Front Pharmacol"},{"key":"13104_CR77","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/cxo.12621","volume":"101","author":"D Subedi","year":"2018","unstructured":"Subedi D, Vijay AK, Willcox M. Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective. Clin Exp Optom. 2018;101:162\u201371. https:\/\/doi.org\/10.1111\/cxo.12621.","journal-title":"Clin Exp Optom"},{"key":"13104_CR78","doi-asserted-by":"publisher","first-page":"e0049622","DOI":"10.1128\/aac.00496-22","volume":"66","author":"RA Stanton","year":"2022","unstructured":"Stanton RA, Campbell D, McAllister GA, Breaker E, Adamczyk M, Daniels JB, et al. Whole-Genome Sequencing Reveals Diversity of Carbapenem-Resistant Pseudomonas aeruginosa Collected through CDC\u2019s Emerging Infections Program, United States, 2016\u20132018. Antimicrob Agents Chemother. 2022;66:e0049622. https:\/\/doi.org\/10.1128\/aac.00496-22.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR79","doi-asserted-by":"publisher","first-page":"e00779","DOI":"10.1128\/AAC.00779-19","volume":"63","author":"S Mikhail","year":"2019","unstructured":"Mikhail S, Singh NB, Kebriaei R, Rice SA, Stamper KC, Castanheira M, et al. Evaluation of the Synergy of Ceftazidime-Avibactam in Combination with Meropenem, Amikacin, Aztreonam, Colistin, or Fosfomycin against Well-Characterized Multidrug-Resistant Klebsiella pneumoniae and Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2019;63:e00779\u201319. https:\/\/doi.org\/10.1128\/AAC.00779-19.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12866-020-01870-z","volume":"20","author":"Q Wang","year":"2020","unstructured":"Wang Q, Zhang F, Wang Z, Chen H, Wang X, Zhang Y, et al. Evaluation of the Etest and disk diffusion method for detection of the activity of ceftazidime-avibactam against Enterobacterales and Pseudomonas aeruginosa in China. BMC Microbiol. 2020;20:187. https:\/\/doi.org\/10.1186\/s12866-020-01870-z.","journal-title":"BMC Microbiol"},{"key":"13104_CR81","doi-asserted-by":"publisher","first-page":"934439","DOI":"10.3389\/fcimb.2022.934439","volume":"12","author":"F Ding","year":"2022","unstructured":"Ding F, Han L, Xue Y, Yang IT, Fan X, Tang R, et al. Multidrug-resistant Pseudomonas aeruginosa is predisposed to lasR mutation through up-regulated activity of efflux pumps in non-cystic fibrosis bronchiectasis patients. Front Cell Infect Microbiol. 2022;12:934439. https:\/\/doi.org\/10.3389\/fcimb.2022.934439.","journal-title":"Front Cell Infect Microbiol"},{"key":"13104_CR82","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.3390\/microorganisms10081660","volume":"10","author":"M Sada","year":"2022","unstructured":"Sada M, Kimura H, Nagasawa N, Akagawa M, Okayama K, Shirai T, et al. Molecular Evolution of the Pseudomonas aeruginosa DNA Gyrase gyrA Gene. Microorganisms. 2022;10:1660. https:\/\/doi.org\/10.3390\/microorganisms10081660.","journal-title":"Microorganisms"},{"key":"13104_CR83","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1128\/AAC.01581-12","volume":"57","author":"S Bruchmann","year":"2013","unstructured":"Bruchmann S, D\u00f6tsch A, Nouri B, Chaberny IF, H\u00e4ussler S. Quantitative contributions of target alteration and decreased drug accumulation to Pseudomonas aeruginosa fluoroquinolone resistance. Antimicrob Agents Chemother. 2013;57:1361\u20138. https:\/\/doi.org\/10.1128\/AAC.01581-12.","journal-title":"Antimicrob Agents Chemother"},{"key":"13104_CR84","doi-asserted-by":"publisher","first-page":"1526843","DOI":"10.3389\/fmicb.2025.1526843","volume":"16","author":"B Secker","year":"2025","unstructured":"Secker B, Shaw S, Hobley L, Atterbury RJ. Genomic and phenotypic characterisation of Pseudomonas aeruginosa isolates from canine otitis externa reveals high-risk sequence types identical to those found in human nosocomial infections. Front Microbiol. 2025;16:1526843. https:\/\/doi.org\/10.3389\/fmicb.2025.1526843.","journal-title":"Front Microbiol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13104-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13104-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:21:01Z","timestamp":1776903661000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13104-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,16]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13104"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13104-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,16]]},"assertion":[{"value":"22 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the research, ethics, and biosafety committees of the National Institute of Paediatrics (IRB: 00008064 and IRB: 00008065) under registration INP 2024\/054. The ethics committee of the National Institute of Paediatrics waived informed consent because the sample collection was part of standard care for hospitalized patients, and the isolates were obtained retrospectively. The patient data were deidentified. This study adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"812"}}